Otoferlin Gene-mediated Hearing Loss Natural History Study

NCT05572073 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2026-03-04

No results posted yet for this study

Summary

This is a retrospective and prospective longitudinal study in participants with Otoferlin Gene-Mediated Hearing Loss.

Conditions

  • Sensorineural Hearing Loss, Bilateral

Interventions

OTHER

Natural History Study

Natural History Study

Sponsors & Collaborators

Principal Investigators

  • Peter Marks, MD · Eli Lilly and Company

Eligibility

Max Age
44 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-14
Primary Completion
2029-02-28
Completion
2029-02-28

Countries

  • United States
  • Australia
  • Germany
  • Spain
  • Taiwan
  • Turkey (Türkiye)
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05572073 on ClinicalTrials.gov